Viewing Study NCT06573151


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2026-02-22 @ 7:05 AM
Study NCT ID: NCT06573151
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-08-27
First Post: 2024-08-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL
Sponsor: Ruijin Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords: